NCT06199011View on ClinicalTrials.gov

Effect of Esketamine on Depressive Symptoms of Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

December 1, 2025

Conditions
Depressive Symptoms
Interventions
DRUG

Esketamine hydrochloride

A standardized non-opioid anesthesia will be achieved by using continuous intraoperative infusion of esketamine.

DRUG

Opioid

A standardized opioid anesthesia will be achieved by using continuous intraoperative infusion of opioids.

All Listed Sponsors
lead

The Second Hospital of Anhui Medical University

OTHER

NCT06199011 - Effect of Esketamine on Depressive Symptoms of Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy | Biotech Hunter | Biotech Hunter